Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype.

This publication has 29 references indexed in Scilit:

• A Novel Skeletal Dysplasia with Developmental Delay and Acanthosis Nigricans Is Caused by a Lys650Met Mutation in the Fibroblast Growth Factor Receptor 3 Gene
  American Journal of Human Genetics, 1999
• Long-term survival in typical thanatophoric dysplasia type 1
  American Journal of Medical Genetics, 1997
• Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3
  Nature Genetics, 1996
• A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia
  Nature Genetics, 1995
• Stop codon FGFR3 mutations in thanatophoric dwarfism type 1
  Nature Genetics, 1995
• A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia
  European Journal of Pediatrics, 1995
• Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3
  Nature Genetics, 1995
• A common FGFR3 gene mutation is present in achondroplasia but not in hypochondroplasia
  American Journal of Medical Genetics, 1995
• A boy with thanatophoric dysplasia surviving 212 days
  Clinical Genetics, 1987
• An infant with thanatophoric dwarfism surviving 169 days
  Clinical Genetics, 1986